As AT-101 disrupts the interactions between Bcl-2 and BIM and separately between Mcl-1 and Noxa, we measured Bcl-2:Bim and Mcl-1:Noxa complex levels in MM cells from patients treated with ARd. This evidence concerns the gene BCL2 and Miyoshi myopathy.